Hear from Dr. Adam Friedman, MD, FAAD, professor and chair of Dermatology at The George Washington University School of Medicine & Health Sciences, discuss the innovative teledermatology psoriasis clinic held at The Pennsylvania Avenue Baptist Church. He is joined by Reverends Kendrick, Ph.D., and Karen Curry, as they discuss why they've opened their church to this program and how they have made this relationship work.

This episode is sponsored by Johnson & Johnson.

How do you define on-treatment remission? As Dr. April Armstrong, M.D., MPH, Professor and Chief of Dermatology at the University of California, Los Angeles, and Dr. Wilson Liao, M.D., Professor and Associate Vice Chair of Research in the University of California, San Fransico Department of Dermatology, that question was not easily answered.

Listen to learn about the new definition, how the working group arrived at it, and how it will benefit patients, payers, and other stakeholders.

Hear from Dr. Mark Lebwohl, MD, Dean for Clinical Therapeutics at the Icahn School of Medicine at Mount Sinai and Professor and Chairman Emeritus of the Kimberly and Eric J. Waldman Department of Dermatology, and Dr. Jason Hawkes, M.D., M.S., co-owner, CSO, and principal investigator at the Oregon Medical Research Center, discuss the intersection of obesity, psoriasis, and GLP-1s.

This podcast was brought to you by Lilly.

Dr. Amy Paller, pediatric dermatologist and clinical researcher at Northwestern Feinberg School of Medicine, and Dr. Ronald Prussick, MD, dermatologist at the Washington Dermatology Center and Vice Chair of the NPF Medical Board, discuss psoriasis and eczema comorbidities in pediatric and adult patients. This podcast is presented in collaboration with the National Eczema Association.

This podcast is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $375,000 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear dermatologists Dr. Kristina Duffin, MD, MS, Professor and Chair of the Department of Dermatology at the University of Utah and Dr. Joel Gelfand, MD, MSCE, FAAD, Director, Psoriasis & Phototherapy Treatment Center at Penn, discuss the Light Treatment Effectiveness (LITE) Study and the data presented at the 2024 AAD Annual Meeting.

The LITE Study is funded with support from the Patient-Centered Outcomes Research Institute (PCORI), an independent research institute authorized by Congress to fund comparative clinical effectiveness research that engages patients and other stakeholders in the research process. This study also benefited from the Daavlin Company's contribution of the phototherapy machines on behalf of this study.

This podcast was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non-government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.

Hear gastroenterologist Dr. Lisa Malter, Professor at the Department of Medicine at NYU Grossman School of Medicine, discuss the intersection between psoriasis and IBD.

This program is supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $351,404, with 2 percentage funded by CDC/HHS and $14.3 million amount and 98 percentage funded by non- government source(s). The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by CDC/HHS, or the U.S. Government.